Market Tracker

12/15 5:15pm ET

ImmunoGen Inc (NASDAQ:IMGN)

6.43
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
1.53
Today|||52-Week Range
8.84
+215.20%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close6.43
Today’s open6.63
Day’s range6.27 - 6.80
Volume10,368,455
Average volume (3 months)3,596,800
Market cap$995.2M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+38.87%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...0.000.00%
NTLAIntellia Therapeutic...0.000.00%
BOLDAudentes Therapeutic...0.000.00%
AMAGAMAG Pharmaceuticals...0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 16, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts